Skip to main content
Back to IDG Capital

IDG Capital's Biotechnology Portfolio

Browse 11 Biotechnology companies funded by IDG Capital. See funding amounts, founder contacts, and investment details.

Biotechnology Companies
11
Total Funding in Biotechnology
$862.1M

Biotechnology Portfolio Companies (11)

Export
BiotechnologyEducationElectronicsHardwareNeuroscience

BrainCo develops brain-computer interface technologies for wellness and education applications.

Somerville, United States
January 2026
$286.4M
Venture - Series Unknown

Founder Contacts

19,000+ verified contacts

BiopharmaBiotechnologyMedical

Puyi Biotech is a new generation nanopore gene sequencing technology developer.

Beijing, China
March 2026
$21.8M
Series B

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth CareProduct Research

MAXVAX aims to provide novel vaccine development and commercialization.

Shuangliu, China
December 2025
Series D

Founder Contacts

19,000+ verified contacts

BiotechnologyLife SciencePharmaceutical

D3 Bio is a biotechnology company focusing on the development and registration of medicines.

Wuxi Shi, China
December 2025
$108.0M
Series B

Founder Contacts

19,000+ verified contacts

Big DataBiotechnologyHealth Care

GV20 Therapeutics is a healthcare company committed to developing better cancer drugs at a faster and lower cost.

Shanghai, China
November 2025
Corporate Round

Founder Contacts

19,000+ verified contacts

BiopharmaBiotechnologyMedical

Hongxin Bio is an mRNA drug developer, focusing on nucleic acid drug delivery and RNA drug development.

Shenzhen, China
August 2025
$14.0M
Seed

Founder Contacts

19,000+ verified contacts

BiopharmaBiotechnologyMedical

Kelun Biotech is a biopharmaceutical company that focuses on the research and development, production and sales of innovative drugs.

Chengdu, China
June 2025
$250.0M
Post Ipo Equity

Founder Contacts

19,000+ verified contacts

Biotechnology

uBriGene is driven by the advancement of gene and cell therapy technologies through research and development.

Miyun, China
December 2024
$27.4M
Series D

Founder Contacts

19,000+ verified contacts

BiotechnologyClinical TrialsHealth CarePharmaceuticalProduct Research

Suns Bio Group is a biopharmaceutical company.

Nantong, China
June 2024
Series D

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth CareMedical

Layerwave Bio is a developer of IVD diagnostic instrument reagents and biomedical scientific research instruments.

Daxing, China
March 2024
$13.8M
Series B

Founder Contacts

19,000+ verified contacts

BiotechnologyOncology

Avistone Pharmaceuticals is a clinical-stage biotechnology company focused on precision oncology therapeutics.

Beijing, China
December 2023
$140.7M
Series B

Founder Contacts

19,000+ verified contacts

Explore IDG Capital's Full Portfolio

View all companies funded by IDG Capital across every industry and funding stage.

View Full IDG Capital Portfolio
IDG Capital Biotechnology Portfolio - 11 Companies | VCBacked